# Phase B Implementation Plan Approval

**Status:** Approved — Phase B complete; execution hold lifted on 2026-11-09  
**Prepared:** 2026-11-08  
**Approved:** 2026-11-08  
**Approver:** Product Owner  
**Execution authorization:** Foundation Task 1 granted on 2026-11-09

## Baseline reviewed

- [Phase B design](../superpowers/specs/2026-11-08-skinlab-phase-b-plan-approval-design.md)
- [Plan index](../superpowers/plans/2026-11-08-skinlab-mvp-plan-index.md)
- [Traceability matrix](../superpowers/plans/2026-11-08-phase-b-traceability-matrix.md)
- [Dependency/gate matrix](../superpowers/plans/2026-11-08-phase-b-dependency-gates.md)
- [Plan review matrix](../superpowers/plans/2026-11-08-phase-b-plan-review-matrix.md)
- [Independent plan review](../reviews/2026-11-08-phase-b-plan-review.md)

## Approved baseline

- A0 Appointment Prototype: plan maturity approved for execution after Foundation Task 1; commencement was held at approval time.
- Foundation Plan: plan maturity approved for execution with fake data only; commencement was held at approval time.
- Plans 2–5: roadmap scope/order approved; just-in-time revalidation remains mandatory.
- Plan 6: roadmap approved; external technical/compliance gates remain mandatory.
- No real patient data, production, or replacement of paper authority is approved.

## Product Owner checks

- [x] A0 is disposable implementation with durable learning.
- [x] A0 prioritizes receptionist/doctor workflow validation over backend learning.
- [x] A0 follows the approved boundary: T+14:59 remains within grace and priority is released at exactly T+15:00.
- [x] After the execution hold is separately lifted, Foundation may initialize the fresh root monorepo and remove nested frontend Git metadata only after its clean-state precondition.
- [x] Incoming expired lots are rejected; near-expiry lots require acknowledgement/reason under item policy.
- [x] Medication stock is reserved before payment/receipt; receipt replacement does not refund or cancel the underlying paid transaction.
- [x] Plans 2–6 must be revalidated before execution.
- [x] External technical/compliance gates cannot be waived by this approval.
- [x] The plan set is approved at the levels recorded above.

## Execution hold at approval time

The Product Owner approved the Phase B baseline but explicitly withheld permission to begin delivery. Until a later explicit instruction lifts this hold, the team and agents must not:

- start Foundation Task 1 or any A0 task;
- remove `admin-skinlab/.git`, initialize root Git, create/push a remote, or create promotion branches;
- install or change dependencies for plan execution;
- create product code, infrastructure, migrations, or prototype code from these plans; or
- treat plan approval as permission to perform implementation commands.

The planned first sequence remains `Foundation Task 1 → A0 Appointment Prototype`, but it is a future candidate sequence, not currently authorized work.

## Effect of approval

All Product Owner checks were signed and independent review had no material open findings; therefore Phase B completed. At that time, no implementation step was authorized and work required a later explicit instruction lifting the hold.

## Subsequent execution authorization

On 2026-11-09, the Product Owner explicitly lifted the hold and authorized Foundation Task 1 to begin. See [`FOUNDATION_EXECUTION_AUTHORIZATION.md`](./FOUNDATION_EXECUTION_AUTHORIZATION.md). This later authorization does not change the fake-data-only, real-data, production, paper-authority, external technical, or compliance boundaries.
